Apomorphine formulation may influence subcutaneous complications from continuous subcutaneous apomorphine infusion in Parkinson’s disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1459
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Apomorphine formulation may influence subcutaneous complications from continuous subcutaneous apomorphine infusion in Parkinson’s disease ; day:1 ; month:7 ; year:2020 ; pages:1-7
Journal of neurology ; (1.7.2020), 1-7
- Creator
-
Hagell, Peter
Höglund, Arja
Hellqvist, Carina
Johansson, Eva-Lena
Löwed, Berit
Sjöström, Anne-Christine
Karlberg, Carina
Lundgren, Margareth
Dizdar, Nil
Johansson, Anders
Willows, Thomas
Rådberg, Johan
Bergquist, Filip
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00415-020-10031-1
- URN
-
urn:nbn:de:101:1-2020083020120480697730
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:46 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hagell, Peter
- Höglund, Arja
- Hellqvist, Carina
- Johansson, Eva-Lena
- Löwed, Berit
- Sjöström, Anne-Christine
- Karlberg, Carina
- Lundgren, Margareth
- Dizdar, Nil
- Johansson, Anders
- Willows, Thomas
- Rådberg, Johan
- Bergquist, Filip
- SpringerLink (Online service)
Other Objects (12)
Continuous subcutaneous apomorphine infusion allowing awake deep brain stimulation in a Parkinson’s disease patient
Feasibility and benefits of home initiation of subcutaneous apomorphine infusion for patients with Parkinson’s disease: the APOKADO study
SUBCUTANEOUS
Model-based comparison of subcutaneous versus sublingual apomorphine administration in the treatment of motor fluctuations in Parkinson’s disease
Psychological aspects in continuous subcutaneous Insulin infusion : A retrospective study
Correction: Model-based comparison of subcutaneous versus sublingual apomorphine administration in the treatment of motor fluctuations in Parkinson’s disease
Intradermal insulin infusion achieves faster insulin action than subcutaneous infusion for 3-day wear
Experiences of Adults Using Continuous Subcutaneous Insulin Infusion: A Qualitative Study
Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson’s Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study
Correction: Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson’s Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study
In-line warming reduces in-line pressure of subcutaneous infusion of concentrated immunoglobulins
Use of continuous subcutaneous anesthetic infusion in cardiac surgical patients after median sternotomy
Continuous subcutaneous apomorphine infusion allowing awake deep brain stimulation in a Parkinson’s disease patient
Feasibility and benefits of home initiation of subcutaneous apomorphine infusion for patients with Parkinson’s disease: the APOKADO study
SUBCUTANEOUS
Model-based comparison of subcutaneous versus sublingual apomorphine administration in the treatment of motor fluctuations in Parkinson’s disease
Psychological aspects in continuous subcutaneous Insulin infusion : A retrospective study
Correction: Model-based comparison of subcutaneous versus sublingual apomorphine administration in the treatment of motor fluctuations in Parkinson’s disease
Intradermal insulin infusion achieves faster insulin action than subcutaneous infusion for 3-day wear
Experiences of Adults Using Continuous Subcutaneous Insulin Infusion: A Qualitative Study
Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson’s Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study
Correction: Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson’s Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study
In-line warming reduces in-line pressure of subcutaneous infusion of concentrated immunoglobulins
Use of continuous subcutaneous anesthetic infusion in cardiac surgical patients after median sternotomy
Continuous subcutaneous apomorphine infusion allowing awake deep brain stimulation in a Parkinson’s disease patient
Feasibility and benefits of home initiation of subcutaneous apomorphine infusion for patients with Parkinson’s disease: the APOKADO study
SUBCUTANEOUS
Model-based comparison of subcutaneous versus sublingual apomorphine administration in the treatment of motor fluctuations in Parkinson’s disease
Psychological aspects in continuous subcutaneous Insulin infusion : A retrospective study
Correction: Model-based comparison of subcutaneous versus sublingual apomorphine administration in the treatment of motor fluctuations in Parkinson’s disease
Intradermal insulin infusion achieves faster insulin action than subcutaneous infusion for 3-day wear
Experiences of Adults Using Continuous Subcutaneous Insulin Infusion: A Qualitative Study
Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson’s Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study
Correction: Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson’s Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study
In-line warming reduces in-line pressure of subcutaneous infusion of concentrated immunoglobulins